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Abstract: A life-threatening massive thromboembolism is reported that developed after laparoscopic splenectomy in a 
57-year-old female with idiopathic thrombocytopenic purpura (ITP). Although asymptomatic, she underwent splenectomy 
because of poor response to steroids and intravenous (IV) gamma globulin. Thirteen days after splenectomy, she 
suffered portal and mesenteric emboli, followed by pulmoner emboli and left popliteal thrombophlebitis. Extensive 
workup for hypercoagulable states was negative. Low molecular weight heparin (LMWH) was initiated at a suboptimal 
dose because of thrombocytopenia. During follow-up, her platelet count increased gradually. Whenever the platelet 
count had remained stable at > 50 x 10
9
/L, she received full dose of LMWH treatment. Over the next 38 days, her pain 
resolved, she tolerated a full diet, and sent home. Follow-up imaging studies demonstrated a recanalized portal vein and 
totally resolved pulmonary arteries. We thought that, consumption of platelets in the massive thromboembolism sites 
including portal, mesenteric and pulmoner vascular beds had resulted in deep thrombocytopenia, which improved 
gradually with anticoagulant therapy.  
Keywords: Portal vein thrombosis, Anticoagulation, Low molecular weight heparin. 
INTRODUCTION 
Splenectomy is performed for diagnosis or 
treatment of a variety of hematologic diseases 
including immune cytopenia, indolent non-Hodgkin’s 
lymphoma, and, rarely, for myeloproliferative diseases 
[1]. Within the recent years, laparoscopic splenectomy 
has been increasingly performed and is associated with 
a decreased rate of intraoperative organ damage and 
quicker postoperative recuperation of the patient [2]. 
Postoperative complications most often comprise 
infections [2]. Additionally, patients with immune 
thrombocytopenia and low platelet counts may have an 
increased perioperative bleeding risk. Thromboembolic 
complications following splenectomy for hematologic 
diseases occur in up to 10% of patients and may range 
from portal vein thrombosis (PVT) to pulmonary 
embolism (PE), and deep vein thrombosis (DVT) [3]. 
Prompt diagnosis is critical and is typically achieved via 
color doppler ultrasonography [4] or computed 
tomography [5]. 
We present a mid-aged woman with the diagnosis 
of ITP who suffered from postsplenectomy massive 
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venous thromboembolism (VTE) including portal, 
splenic, superior and inferior mesenteric, pulmonary 
veins. It was very surprising for us that, she had a deep 
thrombocytopenia at the time of the massive VTE, and 
the extensiveness of the thrombosis was widespread in 
comparison with those reported in the literature. 
Therefore, we decided to share our management of 
this rare and mortal complication, and finally, to review 
the current medical literature.  
CASE PRESENTATION 
A 57-year old female patient with deep 
thrombocytopenia (9 x 10
9
/L) presented to our clinic 
because of prevalant petechiae and bruising on her 
legs. The differential diagnosis of thrombocytopenia 
was carefully evaluated. Endocrinologic and connective 
tissue diseases were excluded. Hepatitis, viral and 
bacterial tests were all negative. She underwent a bone 
marrow biopsy and histologic examination revealed 
normal findings in megacaryocyte morphology and a 
mild increase in myeloid hematopoietic cells. 
Afterwards, the patient was diagnosed as ITP. She had 
received 2 units of apheresis platelets and a short 
course of therapy with peroral methylprednisolone (1 
mg/kg), and a complete remission was obtained with 
this treatment. However, only 2 months later, she 
presented with generalized bruising in her body and the 
platelet count was only 4 x 10
9
/L. A second attempt 
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including 1 unit of apheresis platelets and oral steroid 
was initiated, a second complete remission was 
achieved. A splenectomy was recommended. Because 
the patient had no history of previous abdominal 
surgery, a laparoscopic splenectomy was proposed 
and accepted.  
Laparoscopic splenectomy was carried out at a 
platelet count of 82 x 10
9
/L with no bleeding 
complications, and after quick recovery she was 
discharged on day 3 after an uneventful operation with 
a platelet count of 232 x 10
9
/L. On postoperative day 
16, she presented with a 1-day history of acute 
abdominal pain. Her pain was periumbilical without 
radiation. Her vital signs were in normal ranges, and 
the abdominal examination was significant for mild 
periumblical tenderness without guarding or rebound 
tenderness. Laboratory studies revealed the following: 
white blood cell count (WBC), 21.9 x 10
9
/L; hematocrit, 
33.5%; platelets, 18 x 10
9
/L. Blood chemistries were 
within normal limits except a mild increase in urea (57 
mg/dL, normal range: 10-50) and LDH (314 U/L, 
normal range: 120-247) levels. An abdomen ultrasound 
(US) revealed wall thickness (8 mm) and edema of the 
left intestinal loops. A computed tomography (CT) scan 
of the abdomen and pelvis (Figures 1A, 1B, 1C) 
revealed thrombosis involving the portal vein, 
extending into the branch veins, thrombus of the 
splenic (totally occluded), superior mesenteric, and 
inferior mesenteric veins. Free fluid (51 x 84 mm) at the 
operation site and a significant amount of pelvic free 
fluid, wall thickness and edema of the jejunal loops 
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Figure 1. Thrombosis of portal vein and pulmonary artery. Axial (A) and coronal (B) contrast enhanced CT images demonstrate 
hypodense filling defects (arrows) in portal veins consistent with portal vein thrombosis. (C) Coronal contrast enhanced CT 
reveals thrombosis of superior mesenteric vein (arrow). (D) Axial contrast enhanced CT reveals hypodense filling defect (arrow) 
resulting in partial thrombus of pulmonary artery.  
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located at the left upper quadrant were also reported 
(venous ischaemia). A thorax CT scan (Figure 1D) 
showed filling defects compatible with pulmonary 
emboli in the main pulmonary artery, bilateral lobar 
arteries, and some segmented and subsegmented 
branches. In addition, a venous Doppler US of lower 
extremities revealed left popliteal thrombophlebitis.  
Oral intake was stopped after diagnosis of multiple 
thrombosis in vessels. Intravenous immunoglobulin 1 
gr/kg, for 2 days was administered, and her platelet 
count rose to 28 x 10
9
/L. Surgery department 
recommended conservative approaches, but not a re-
operation. Low molecular weight heparin (enoxaparin, 
Clexane®, 4000 anti-Xa IU/0.4 ml) was initiated at a 
suboptimal dose because of thrombocytopenia. 
Unfortunately, an upper gastrointestinal hemorrhage 
presenting with melena occurred. Therefore, we had to 
stop LMWH. The patients’ relatives did not accept the 
endoscopic examination. One day later, gastrointestinal 
bleeding was stopped and we started LMWH at a low 
dose again. This time gastrointestinal bleeding did not 
repeat. During follow-up, her platelet count increased 
gradually as shown in Figure 2. Whenever the platelet 
count had remained stable at > 50 x 10
9
/L, she 
received full dose of LMWH treatment. At discharge, 
her medical management included oral diet of normal 
foods, and anticoagulation with LMWH. 
She had no prior history of thrombophilia, and 
exhibited no further obvious clinical risk factors for 
thromboemboly, such as prolonged immobilization, 
infection or heart failure. A workup for 
hypercoagulability states (factor V G1691A, factor II 
G20210A, MTHFR C677T mutations, protein C and S 
deficiency, anti-cardiolipin IgA, G, M) yielded normal 
results. However, she had heterozygous MTHFR 
A1298C, PA-I 4G/5G and -fibrinogen gene 455 G>A 
mutations. Fluorescently labeled inactive toxin 
aerolysin (FLAER) panel was performed to exclude 
paroxysmal nocturnal hemoglobinuria (PNH), and did 
not reveal any PNH clones in granulocytes or 
monocytes. The cluster of differentiation (CD) 15 and 
CD 24 in granulocytes, CD 14 and CD 64 in 
monocytes, CD 59 and GpA in erytrocytes, and CD 45 
were all found to be 100%.  
Coronal contrast enhanced CT obtained three and a 
half months after initial CT demonstrated venous 
collaterals (Figure 3) at portal hilus consistent with 
cavernous transformation. A follow-up thorax CT scan 
3.8 months postsplenectomy showed the resolution of  
  
 
Figure 3. Recanalized portal vein. Coronal contrast enhanc- 
ed CT obtained three and a half months after initial CT 
demonstrates venous collaterals (arrow) at portal hilus 
consistent with cavernous transformation. 
0
50
100
150
200
250
2
8
.1
0
.2
0
1
3
1
1
.1
1
.2
0
1
3
2
5
.1
1
.2
0
1
3
0
9
.1
2
.2
0
1
3
2
3
.1
2
.2
0
1
3
0
6
.0
1
.2
0
1
4
2
0
.0
1
.2
0
1
4
0
3
.0
2
.2
0
1
4
1
7
.0
2
.2
0
1
4
D a t e
P
la
t
e
le
t
 
c
o
u
n
t
Platelet count ( x 109/
 
Figure 2. Platelet count (x 10
9
/L) of the patient during follow-up. 
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the pulmonary emboli (Figure 4). She is currently well 
with LMWH. To date, the patient remains clinically 
stable and asymptomatic. 
 
 
 
 
 
 
  
Figure 4. Contrast enhanced axial CT of patient after 
anticoagulant treatment demonstrates bilateral contrast 
material filled pulmonary arteries (arrows). No thrombus was 
observed in the pulmonary arteries. 
DISCUSSION 
The pathogenesis of thromboembolism after 
splenectomy is poorly understood. In several reports, 
thrombocytosis, large spleen size, and a 
myeloproliferative disease (MPD) as the underlying 
disease were described as risk factors [6, 7]. Patients 
with a large spleen (>3,000 g) and MPD had a 75% 
incidence of portal vein thrombosis (PVT) [6].  
Postoperative PVT was more likely to occur in 
patients with hematological diseases (2% vs 10%) in a 
large Dutch study [8]. Postsplenectomy thrombocytosis 
in myeloid metaplasia patients was associated with 
postoperative thrombosis [9]. However, the association 
of postsplenectomy thrombocytosis and PVT is 
unclear, particularly in patients without MPD [6]. 
Although quantitative changes in platelet levels have 
been shown not to correlate with the development of 
postsplenectomy splanchnic venous thrombosis [10], 
qualitative changes in platelet function have been 
suggested to play a role in thrombotic tendencies [11]. 
In this patient, laparoscopic surgery, postoperative 
period and lack of anticoagulant prophylaxis after 
surgery seem to be probable responsibles of the 
thromboembolic state. We thought that, consumption of 
platelets in the massive theromboembolism sites 
including portal, mesenteric and pulmoner vascular 
beds had resulted in deep thrombocytopenia, which 
improved gradually with anticoagulant therapy.  
Portal vein thrombosis may result from local factors, 
such as intraoperative manipulation of visceral vessels, 
the splenic vein in particular [12], and may account for 
the particular risk in patients with massively enlarged 
organs. For this reason, appropriate surgical technique 
for splenectomy should also be carefully considered in 
patients with hematological diseases. 
Laparoscopic splenectomy has become an 
important option in early 1990s [13-21]; because it 
offers the advantages of minimally invasive surgery to 
these anemic, trombocytopenic or immune suppressed 
patients. There are many reports in the literature, which 
compare open and laparoscopic splenectomy [22-28]. 
They show comparable mortality and lower morbidity 
with longer operation time, shorter duration of 
hospitalization, lesser postoperative complications, 
greater patient comfort and earlier return to normal 
daily life with laparoscopic procedure. Ozdemir et al. 
performed laparoscopic splenectomy for ten patients 
with hematological diseases and found it safe and 
efficaeus in these patients. Postoperative PVT was 
reported in one patient (10%) with thalassemia minor. 
She received anticoagulation therapy for 3 months, and 
she is still using acetylsalicilic acid [29]. Similarly, 
Harris et al. reported portal vein thrombosis after 
laparoscopic splenectomy in 2 (14%) of 14 patients 
[30]. Both patients had ITP. Preoperatively, all patients 
received a subcutaneous injection of heparin. These 
two studies suggest that, the risk of PVT after 
laparoscopic splenectomy is at least as for open 
splenectomy. However, in a retrospective analysis by 
Svensson et al., PVT was diagnosed in five of 37 
(13.5%) patients with hematological malignancies, four 
after open splenectomy and only one after laparoscopic 
splenectomy. The authors recommended careful 
observation and prolonged thromboprophylaxis for 
these patients that seem to have a high risk of 
developing PVT after splenectomy [31].  
The elevated intraabdominal pressure associated 
with the creation of the pneumoperitoneum necessary 
for a laparoscopic procedure can lead to blood stasis in 
the portal system. Normal portal venous pressure is in 
the range of 10–12 mmHg. Significant hemodynamic 
changes have not been seen, however, when a 
pneumoperitoneum of 12 mmHg is employed [32]. 
Hypercoagulability also places the patient at high 
risk for PVT. However, there exists little data on 
activation of plasmatic coagulation and/or lack of 
coagulation inhibitors, such as protein C, S, or 
antithrombin III deficiency after splenectomy or the 
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presence of the factor V Leiden mutation or 
antiphospholipid antibodies. Few reports demonstrated 
a systemic hypercoaguable state in patients with PVT 
[12, 33]. Our patient had heterozygous MTHFR 
A1298C, PA-I 4G/5G and -fibrinogen gene 455 G>A 
mutations. Folic acid replacement two days a week 
was started.  
Mesenteric thrombosis, as was also seen in our 
patient, is associated with a poor prognosis due to 
subsequent bowel ischemia and multiorgan failure [6, 
33, 34]. In cases of acute mesenteric thrombosis, most 
authors agree that prompt intravenous anticoagulation 
is warranted [35-37]. Early anticoagulation promotes 
recanalization of the portal vein and reduces the risk of 
splanchnic venous infarction without increasing the risk 
of variceal bleeding [38, 39]. The probability of 
recanalization is related to the extent of thrombosis 
[39]. Our patient suffered from both superior and 
inferior mesenteric vein thrombosis which could be 
resulted with bowel ischaemia and massive 
gastrointestinal bleeding. At the follow-up, under 
anticoagulant therapy, a gastrointestinal bleeding 
occurred and controlled after withdrawal of LMWH.  
Acute abdomen caused by thrombosis of the portal 
and superior mesenteric veins in a splenectomized 
female ITP patient was reported by Spanish 
investigators. They performed local fibrinolysis 
successfully through a percutaneous transhepatic 
catheter [40]. More recently, 2 patients who underwent 
splenectomy for ITP developed portal and mesenteric 
vein thromboses. Both were treated successfully with 
anticoagulants for 3 months until the thrombi 
regressed, as shown by CT scan [41].  
Portal vein thrombosis is usually diagnosed in 
symptomatic patients. Because screening for clinically 
occult portal vein thrombosis is not routine, it has been 
suggested that its true incidence is underestimated [42-
44]. The recommendation to perform routine screening 
remains controversial [45]. Petit and colleagues [44] 
suggested that screening 2 weeks postoperatively may 
be preferable. Currently, color-flow Doppler ultrasound 
and contrast-enhanced CT scans are the best methods 
for the nonoperative diagnosis of PVT. Doppler 
ultrasound has a higher sensitivity than CT and is 
relatively inexpensive to perform [44]. However, CT 
evaluation may be more accurate during the 1st 
postoperative week because bowel distention and ileus 
may limit ultrasound examination. The flexibility of 
Doppler ultrasound in allowing the visualization of 
vessels along their long axes is a clear advantage [46]. 
Venous thromboembolism occurs in approximately 
10% of splenectomized patients, and prophylactic 
anticoagulation is warranted in patients undergoing 
splenectomy for hematologic diseases [3]. The most 
appropriate duration of anticoagulant therapy is 
unknown, but some authors have demonstrated 
success with oral anticoagulation for 3 months, [47] 
and a general guideline of 6 months to 1 year has also 
been suggested [48]. To the best of our knowledge, 
duration and intensity of mandatory anticoagulation has 
yet to be established. 
It was felt that ITP patients with a bleeding diathesis 
were likely at low risk of thrombosis. However, this 
assumption is likely not valid for hematologic malignant 
conditions. A retrospective analysis of 49 patients 
underwent splenectomy for primary/relapsing refractory 
ITP were analyzed in the absence of anticoagulant 
prophylaxis. The VTE rates of laparoscopic and open 
surgery were similar (9.5 vs 10.7%), and patients at 
risk were those who have had an exponential rise of 
the platelet counts [49]. More recently, among 9976 
patients with ITP, 1762 of whom underwent 
splenectomy, the cumulative incidence of abdominal 
VTE was 1.6% compared with 1% in patients who did 
not undergo splenectomy. As expected, the increased 
risk of abdominal VTE was more pronounced <90 days 
after splenectomy, but not late [50]. These 2 studies 
had clearly stated that, postsplenectomy, ITP should be 
considered as a thrombophilic condition. 
CONCLUSIONS 
Splenectomy for hematological disorders (even with 
low platelet counts), and laparoscopic splenectomy are 
associated with increased risk of venous thrombosis, 
especially for portal and mesenteric vein thrombosis. 
Anticoagulation with LMWH for an extented period may 
be a beneficial prophylaxis regimen in patients 
undergoing general surcical procedures. Routine 
surveillance for portal vein thrombosis may be 
advisable after laparoscopic splenectomy, especially in 
patients with additional risk factors for thromboembolic 
disease. Prompt diagnosis and mandatory therapy 
should be based on each patient’s clinical 
circumstances and the abilities of individual institutions. 
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